XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)

Grant

Date/time Interval

  • August 12, 2016 - September 23, 2019
  • Total Award Amount

  • 86418.00
  • Direct Costs

  • 58788.00
  • Sponsor Award Id

  • 769K742
  • Contributor

  • Erica Stringer-Reasor M.D.   Investigator  
  • Helen Krontiras M.D.   Principal Investigator  
  • Jennifer De Los Santos   Investigator